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Resumo
Introdução: No Brasil, não existem instrumentos válidos para 
medir a disfunção cognitiva subjetiva no transtorno bipolar. O 
presente estudo analisou as propriedades psicométricas da Escala 
de Disfunções Cognitivas no Transtorno Bipolar (COBRA) em 
uma amostra brasileira de pacientes bipolares. Adicionalmente, 
investigamos a relação entre a COBRA, medidas cognitivas 
objetivas e curso da doença.
Métodos: A amostra total (n=150) incluiu 85 pacientes com 
transtorno bipolar e 65 controles saudáveis. As propriedades 
psicométricas da COBRA (consistência interna, validade 
concorrente, validade discriminativa, análise fatorial, curva ROC 
e fidedignidade) foram analisadas.
Resultados: A COBRA apresentou estrutura de um fator com 
alta consistência interna (alfa de Cronbach=0,890). A validade 
concorrente ficou demonstrada pela forte correlação com o 
domínio cognitivo da FAST (r=0,811, p<0,001). Pacientes 
bipolares tiveram mais queixas cognitivas [média=14,69; desvio 
padrão (DP)=10,03] que os controles (média=6,78; DP=5,49; 
p<0,001), sugerindo a validade discriminativa do instrumento. 
Não houve correlação significativa entre a COBRA e medidas 
cognitivas objetivas. Além disso, escores mais altos na COBRA 
estiveram associados com sintomas residuais depressivos 
(r=0,448; p<0,001) e maníacos (r=0,376; p<0,001), número de 
episódios depressivos (r=0,306; p=0,011), número de episódios 
totais (r=0.256; p=0.038) e tentativas de suicídio (r=0,356; 
p=0,003).
Conclusão: A COBRA é um instrumento válido para avaliar 
queixas cognitivas, e o uso combinado das medidas cognitivas 
subjetivas-objetivas possibilita a correta identificação das 
disfunções cognitivas no transtorno bipolar.
Descritores: Transtorno bipolar, cognição, testes 
neuropsicológicos, queixas cognitivas.
Abstract
Introduction: In Brazil, there is no valid instrument to measure 
subjective cognitive dysfunction in bipolar disorder. The present 
study analyzed the psychometric properties of the Cognitive 
Complaints in Bipolar Disorder Rating Assessment (COBRA) in 
Brazilian bipolar patients. We further investigated the relationship 
between the COBRA, objective cognitive measures, and illness 
course variables.
Methods: The total sample (N=150) included 85 bipolar 
disorder patients and 65 healthy controls. The psychometric 
properties of the COBRA (e.g., internal consistency, concurrent 
validity, discriminative validity, factor analyses, ROC curve, and 
feasibility) were analyzed.
Results: The COBRA showed a one-factor structure with very 
high internal consistency (Cronbach’s alpha=0.890). Concurrent 
validity was indicated by a strong correlation with the cognitive 
domain of the FAST (r=0.811, p<0.001). Bipolar patients 
experienced greater cognitive complaints (mean=14.69; standard 
deviation [SD]=10.03) than healthy controls (mean=6.78; 
SD=5.49; p<0.001), suggesting discriminative validity of the 
instrument. No significant correlations were found between 
the COBRA and objective cognitive measures. Furthermore, 
higher COBRA scores were associated with residual depressive 
(r=0.448; p<0.001) and manic (r=0.376; p<0.001) symptoms, 
number of depressive episodes (r=0.306; p=0.011), number 
of total episodes (r=0.256; p=0.038), and suicide attempts 
(r=0.356; p=0.003).
Conclusion: The COBRA is a valid instrument to assess cognitive 
complaints, and the combined use of subjective-objective 
cognitive measures enables the correct identification of cognitive 
dysfunctions in bipolar disorder.
Keywords: Bipolar disorder, cognition, neuropsychological tests, 
cognitive complaints.
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Introduction
Cognitive dysfunction in bipolar disorder (BD) 
occurs across several domains, including attention, 
verbal memory and executive function.1,2 These 
deficits are not only present during acute mood 
episodes, but persist, in some degree, into periods 
of remission.3,4 In addition, cognitive dysfunction 
may predict functional impairment5,6 and treatment 
adherence.7,8 Thus, the correct identification and 
treatment of cognitive dysfunction in BD is critical 
and would help improve functioning and quality of life 
for patients with BD.9 
In the last two decades, cognitive function has 
become one of the most important construct to 
be evaluated in psychiatry, both clinically and in 
research. Indeed, emerging evidence has highlighted 
the relevance of assessing cognitive performance in 
BD.10,11 However, the ideal methodology for assessing 
cognition in mental illness is still subject of debate in 
the literature. Whereas objective cognitive measures 
(e.g., neuropsychological tests) allow us to assess 
cognitive performance of an individual as compared 
to the normative population, subjective cognitive 
measures tend to assess the subject’s cognitive 
function in comparison to their own premorbid 
levels.10-12 Furthermore, the patient’s perception 
of their cognitive function is an important issue 
and should be considered. Therefore, an adequate 
assessment of cognition requires not only objective 
neuropsychological tests but also subjective cognitive 
measures.10
Although there are several instruments evaluating 
subjective cognitive dysfunction in patients with 
mental disorders,13-16 most of them do not specifically 
detect cognitive deficits experienced by patients with 
BD. In this context, the Cognitive Complaints in Bipolar 
Disorder Rating Assessment (COBRA) was carefully 
designed to assess cognitive difficulties associated 
with the main deficits experienced by patients with BD 
as reported in the literature.11 Currently, the COBRA 
is available in distinct languages (such as Spanish, 
English, French Chinese, Danish, Japanese) and has 
been used in both research and clinical practice in 
various cultures.11,12,17-19
In Brazil, there is no clinically feasible screening 
scale to assess cognitive difficulties in BD, indicating 
the importance to validate instruments in this 
regard. The main aim of the current study was to 
examine the psychometric properties of the COBRA 
among Brazilian patients with BD. In addition, we 
investigated the relationship between the COBRA scale, 
neuropsychological tests, and the course of the illness. 
Methods 
Participants
Eighty-five patients with BD were recruited from 
the Programa de Atendimento do Transtorno de Humor 
Bipolar (PROTHABI), at Hospital de Clínicas de Porto 
Alegre, in southern Brazil, between October 2015 
and July 2017. The inclusion criteria were: 1) having 
a diagnosis of BD according to the Diagnostic and 
Statistical Manual of Mental Disorders, 5th edition (DSM-
5); 2) being 18 to 70 years old; 3) meeting criteria 
for euthymia for at least one month previous to the 
assessment, defined as a score ≤7 on the Hamilton 
Depression Rating Scale (HAM-D)20 and the Young Mania 
Rating Scale (YMRS).21 Exclusion criteria were: 1) having 
any medical or comorbid psychiatric condition affecting 
neuropsychological performance and current drug or 
alcohol dependence or abuse; and 2) having undergone 
electroconvulsive therapy within the past year. 
Sixty-five healthy controls who had no current or 
previous history and no first-degree family history of a 
major psychiatric disorder, including dementia or mental 
retardation, assessed by the non-patient version of the 
Structured Clinical Interview for DSM-IV-TR (SCID), 
were recruited from the general population within the 
catchment area of Hospital de Clínicas de Porto Alegre. 
This study was approved by the ethics committee of 
Hospital de Clínicas de Porto Alegre. Following verbal 
description of the study objectives and details, all 
participants signed a written informed consent form. 
Assessment
Clinical and demographic features
All participants’ demographic, clinical and 
pharmacological data were obtained through a 
structured interview and from medical records. The 
17-item HAM-D20 and the YMRS21 were administered 
by trained raters to assess depressive and manic 
symptoms, respectively.
Functional status
The overall functional outcome was assessed 
using the Functioning Assessment Short Test (FAST), 
an instrument widely used in patients with BD. This 
scale includes 24 items that evaluate six functional 
domains (autonomy, occupational functioning, cognitive 
functioning, financial issues, interpersonal relationships, 
and leisure time). The higher the score, the greater the 
disability.22
Subjective cognitive measure
The COBRA is a 16-item self-report instrument 
that allows to measure subjective cognitive difficulties 
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including executive function, processing speed, working 
memory, verbal learning and memory, attention/
concentration, and mental tracking. All items are rated 
using a 4-point scale: 0 = never, 1 = sometimes, 2 
= often, and 3 = always (see Portuguese and English 
versions in Appendix 1). The total score is obtained by 
adding up the scores of every item. The higher the score, 
the higher the number of subjective complaints.11
The linguistic adaptation of the COBRA started with 
a document in Portuguese obtained by the translation/
back-translation method. The items not resulting in 
appropriate wording equivalence with the original 
text were analyzed by the team of investigators and 
the translators until they agreed upon an appropriate 
expression. Subsequently, two bilingual authors (TAC 
and ARR) evaluated the degree of equivalence between 
the original English and the Portuguese version.
Objective cognitive measure
Based on the consensus of the International 
Society for Bipolar Disorders-Battery for Assessment 
of Neurocognition (ISBD-BANC),23 all participants 
completed a comprehensive neuropsychological battery 
in order to assess different cognitive domains, as 
follows: 
- Processing speed: Phonemic Verbal Fluency 
(F-A-S)24 and Trail Making Test–Part A 
(TMT-A)25;
- Working memory: Letter-Number Sequencing 
Subtest WAIS-III (LNS)26,27;
- Verbal learning and memory: Hopkins Verbal 
Learning Test - Revised (HVLT-R)28;
- Executive functions: Stroop Color-Word 
Test (SCWT)29 and Trail Making Test–Part B 
(TMT-B)25;
- Attention: Continuous Performance Test – 
Identical Pairs (CPT-IP);
- Social cognition: Reading the Mind in the Eyes 
Test – Revised (RMET-R)30;
- Estimated intelligence quotient (IQ): Wechsler 
Abbreviated Scale of Intelligence (WASI) - 
vocabulary and matrix reasoning subtests.31,32
Validity and reliability assessment 
Internal consistency reliability of the COBRA was 
assessed using Cronbach’s α coefficient. Concurrent 
validity was assessed in three ways: 1) to examine the 
relationship between COBRA results and the cognitive 
domain of the FAST; 2) to investigate the association 
between the COBRA and objective cognitive measures 
(neuropsychological battery); and 3) to investigate 
possible correlations between the COBRA and course 
of the illness. Validity as a discriminative measure to 
detect differences between patients with BD and healthy 
controls was analyzed using parametric independent 
t-tests. The optimal point for the COBRA was determined 
by means of a receiver operating characteristic (ROC) 
curve. An exploratory factor analysis by the principal axis 
factoring method (quartimax with Kaiser normalization) 
was performed to describe the internal structure of 
the COBRA. Finally, feasibility was described as the 
percentage of patients and controls who did respond to 
the questionnaire in its entirety.
Statistical analysis 
Statistical analysis was performed using the Statistical 
Package for the Social Sciences (SPSS) for Windows, 
version 18.0. Internal consistency was assessed using 
Cronbach’s alpha. Spearman’s correlation coefficients 
were calculated to examine the possible relationship 
between the COBRA, FAST, neuropsychological and 
clinical variables. Group comparisons (patients and 
controls) were made using parametric t-tests. The 
rotation was performed using the quartimax method 
and the ROC curve was used to detect the optimal point 
to discriminate between patients and controls.
Results 
A total of 150 subjects (85 patients with BD and 65 
healthy volunteers) were included in the study. Sixty-
one (71.8%) patients and 46 (78.0%) controls were 
women (p=0.240). The mean age of the patients was 
49.60 (12.88) years, and that of the controls was 45.85 
(15.68) years (p=0.121). Other sociodemographic and 
clinical characteristics of the sample are shown in Table 1.
Internal consistency 
The internal consistency coefficient obtained was 
high, with Cronbach’s alpha=0.890 for the total 16-
item scale, suggesting that the items are sufficiently 
homogeneous. 
Associations between COBRA and FAST 
A strong correlation was found between the COBRA 
total score and the cognitive domain of the FAST scale, 
indicating the concurrent validity of the instrument 
(r=0.811, p<0.001; Figure 1).
Associations between subjective and objective 
cognitive measures 
Spearman correlations were performed to assess the 
relationship between subjective and objective cognitive 
measures in both groups. No significant correlation 
was found between the COBRA and neuropsychological 
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tests among the patients (p-values >0.107). In the 
control group, a negative significant correlation was 
found between the COBRA and HVLT-R (p=0.006; other 
p-values >0.072).
Associations between subjective cognitive 
measures and course of illness 
The COBRA was positively correlated with total 
number of mood episodes (r=0.256; p=0.038), number 
of depressive episodes (r=0.306; p=0.011), number 
of suicide attempts (r=0.356; p=0.003), residual 
depressive symptoms (r=0.448; p<0.001), and manic 
symptoms (r=0.376; p<0.001; Table 2). 
Validity as a discriminative measure to detect 
differences between patients with BD and healthy 
controls
Patients with BD showed higher COBRA total scores 
(mean=14.69; standard deviation [SD]=10.03) than 
healthy controls (mean=6.78; SD=5.49; p<0.001; 
Figure 2).
ROC curve 
We analyzed the scale’s ability to discriminate 
between patients and controls by means of the 
diagnostic performance or ROC curve. The area under 
the curve was 0.752 (95% confidence interval [95%CI] 





Sex (female), n (%) 46 (78.0) 61 (71.8) 0.240
Age (years) 45.85 (15.68) 49.60 (12.88) 0.121
Years of education 14.71 (4.08) 10.67 (4.02) <0.001
Married, n (%) 30 (46.2) 38 (45.8) 0.964
Employed, n (%) 30 (46.2) 19 (22.9) 0.003
Age at onset (years) 33.63 (12.53)
Number of hospitalizations 4.21 (5.17)
Number of (hypo)manic episodes 6.25 (4.93)
Number of depressive episodes 6.12 (5.14)
Number of total episodes 12.48 (8.71)
Duration of illness (years) 15.66 (9.54)
Number of suicide attempts 1.27 (1.44)
Psychotic symptoms at first episode 48 (61.5%)
HAM-D score 3.52 (2.12)
YMRS score 1.17 (1.44)
Data presented as mean (standard deviation), unless otherwise specified.
BD = bipolar disorder; HAM-D = Hamilton Depression Rating Scale; SD = standard deviation; YMRS = Young Mania Rating Scale.
Figure 1 - Concurrent validity of the COBRA. Spearman 
correlation between COBRA and the cognitive domain score of 
FAST scale (r=0.811; p<0.001). COBRA = Cognitive Complaints 
in Bipolar Disorder Rating Assessment; FAST = Functioning 
Assessment Short Test.
Table 2 - Spearman’s correlation coefficients between COBRA 




Age at onset 0.026 (0.821)
Total number of episodes 0.256 (0.038)
Number of depressive episodes 0.306 (0.011)
Number of manic episodes 0.161 (0.191)
Number of hospitalizations 0.005 (0.966)
Number of suicide attempts 0.356 (0.003)
Duration of illness 0.136 (0.233)
HAM-D score 0.448 (<0.001)
YMRS score 0.376 (<0.001)
COBRA = Cognitive Complaints in Bipolar Disorder Rating Assessment; 
HAM-D = Hamilton Depression Rating Scale; SD = standard deviation; 
YMRS = Young Mania Rating Scale.
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0.674-0.829), i.e., close to 1, indicating good capacity. 
The discriminative capacity analysis indicated that a 
score of 10 obtains the best balance between sensitivity 
(64.7%) and specificity (72.3%; Figure 3).
Factor analysis
The study of the internal structure of the COBRA, 
after rotation (using the quatrimax method), determined 
a three-factor structure, as shown in Table 3. However, 
only two items were loaded in the second factor, and 
one item in the third factor. As values loaded in the 
second factor and third factor were very close to the 
first load, we confirmed the original one-factor structure 
with 38.42% of the total variance. 
Feasibility 
Finally, the results showed a high feasibility of the 
COBRA, since the totality of participants answered all 
items of the instrument.
Discussion
The results of the present study demonstrated 
that the COBRA is a valid method to assess cognitive 
complaints in Brazilian patients with BD. The instrument 
exhibited satisfactory psychometric properties, with 
very high internal consistency and convergent validity 
as indicated by a strong correlation with the cognitive 
domain of the FAST. As expected, COBRA total scores 
were higher in patients compared to healthy controls, 
suggesting the discriminative validity of the instrument. 
The cut-off point to discriminate subjective cognitive 
function between patients and controls was the same 
found in the Spanish validation study (>10) and similar 
to the Chinese study (>11). Furthermore, the COBRA 
presented a one-factor structure, which means that 
patients tend to perceive their deficits as a global 
cognitive dysfunction rather than to discriminate 
deficits in specific cognitive domains. Our finding is 
consistent with previous validation studies with BD 
in other countries.11,12,17,19 The Portuguese version of 
Figure 2 - Mean and standard deviation of COBRA between 
patients and controls. COBRA = Cognitive Complaints in Bipolar 
Disorder Rating Assessment. * p<0.001.
Figure 3 - ROC curve between patients and controls. The area 
under the curve was 0.752 (95%CI 0.674-0.829). Cut-off point 
10 indicates the best balance between sensitivity (64.7%) and 
specificity (72.3%). 95%CI = 95% confidence interval; ROC = 
receiver operating characteristic.
















Item 4 0.473 0.591
Item 3 0.516 0.534
Item 2 0.479 0.543
COBRA = Cognitive Complaints in Bipolar Disorder Rating Assessment. 
Extraction method: principal axis factoring (quartimax rotation with Kaiser 
normalization).
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the COBRA is now ready and available to be used as 
a subjective cognitive measure in clinical practice and 
research settings.
The weak correlation found between the COBRA 
and neuropsychological tests in the current study is 
in agreement with previous findings. For instance, the 
Spanish study showed significant correlations between 
the COBRA and some neuropsychological tests, 
particularly in single measures related to executive 
function, working memory, verbal, and visual memory.11 
A recent research in Japan observed no association 
between the COBRA and objective neurocognitive 
battery, except for COBRA and processing speed.19 Xiao 
et al.17 did not find relationships between the COBRA 
and the Montreal Cognitive Assessment (MoCA) total 
score. However, significant correlations were found 
between the COBRA and single measures related 
to executive function and verbal memory. A study 
conducted in Denmark12 showed a poor association 
between objective cognitive measures and the COBRA. 
In particular, COBRA total scores correlated with working 
memory and executive skills on the neuropsychological 
tests and on the Screen for Cognitive Impairment in 
Psychiatry (SCIP). In contrast, we found a correlation 
between the COBRA and verbal memory in healthy 
controls. Possibly, some patients with BD have more 
difficulties in reporting correctly their cognitive deficits 
or have more difficulties in expressing their cognitive 
deficits. Taken together, these findings support the 
idea that subjective cognitive measures are not a 
direct expression of objective cognitive measures.18 
In particular, the COBRA is a self-report instrument 
expressing patients’ opinion of their cognitive difficulties 
in daily lives, which is not always congruent with results 
obtained by objective neuropsychological tests that 
compare patients’ performance with a normative group, 
and therefore reflect different aspects of cognition. 
In addition, as objective and subjective cognitive 
measures may capture somewhat different processes, 
some authors have suggested that simple correlational 
analysis between overall scores of subjective cognitive 
measures and neuropsychological tests may limit the 
understanding of this disagreement.10 In this sense, 
Miskowiak et al.10 proposed a novel methodology to 
quantify the degree and direction of the subjective-
objective discrepancy, as well to explore predictors of 
discrepancy. Their findings indicated that some patients 
seem to have a relatively accurate sense of their cognitive 
abilities, whereas others may overreport or underreport 
cognitive difficulties. In particular, patients with more 
mood symptoms, greater illness chronicity, BD type 
II, and male gender showed greater subjective than 
objective cognitive impairment, whereas patients with 
high premorbid IQ underreported objective cognitive 
impairment. Further studies are required to investigate 
concordance and discrepancy between subjective and 
objective cognitive measures as this understanding 
could guide the clinical assessment and treatment of 
cognitive dysfunction in BD. 
Another interesting finding of the present study 
was that patients with more subsyndromal depressive 
and manic symptoms experienced greater cognitive 
complaints, suggesting that mood symptoms may 
influence self-assessment of cognitive difficulties. The 
impact of depressive symptoms on subjective cognitive 
measures has been consistently demonstrated in many 
studies.11,18 For instance, using a multiple regression 
analysis, Ott et al.18 identified depressive symptoms as 
the best predictor of subjective cognitive dysfunction 
in a unipolar disorder sample. Indeed, there is a trend 
toward increased subjective cognitive complaints 
alongside increased depressive symptomatology. 
A possible explanation for these findings is that 
depressive symptoms, albeit residual, lead to a negative 
perception of cognitive ability in these individuals, 
affecting their functioning. Conversely, it is possible to 
speculate that the patient’s perception of themselves 
as less competent may contribute to the worsening of 
depressive symptoms. 
Furthermore, other clinical variables such as number 
of depressive episodes, number of total episodes, and 
suicide attempts were strongly correlated with overall 
COBRA score. However, the relation between subjective 
cognitive measures and clinical course of the illness 
is complex. Probably, those patients with more illness 
chronicity represent a subgroup with poor insight, 
which, in turn, may affect their self-report cognitive 
assessment. To sum up, these findings highlight that 
subclinical depressive symptoms, among other variables, 
may act as mediators or confounders, affecting the poor 
association between objective and subjective cognitive 
measures. 
The present study has a number of limitations. First, 
this was a cross-sectional study, conducted in a tertiary 
hospital, where participants tend to present more 
severe symptoms, which may limit the generalization 
of the findings. Second, all our patients were on 
pharmacological treatment, which may have affected 
the cognitive assessment. Third, as there is not a gold 
standard instrument to assess subjective cognitive 
function in Brazil, we used the cognitive domain of the 
FAST to perform convergent validity analysis. 
In conclusion, our findings showed that the 
Portuguese version of the COBRA is a valid and feasible 
instrument to assess cognitive complaints in BD. As 
objective and subjective measures assess distinct 
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aspects of cognition, the combined use of subjective-
objective instruments may greatly contribute to improve 
our knowledge of the nature and extent of cognitive 
dysfunctions in BD. Finally, the correct identification 
of cognitive dysfunctions would allow us to implement 
specific therapeutic strategies to improve cognition and 
functioning in BD. 
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Appendix 1 - Portuguese and English versions of the Cognitive Complaints in Bipolar Disorder Rating Assessment (COBRA) 
Portuguese version English version 
Escala de Disfunções Cognitivas no Transtorno Bipolar 
(COBRA)
Cognitive Complaints in Bipolar Disorder Rating 
Assessment (COBRA)
1.  Você tem dificuldade para se lembrar do nome das pessoas? 1.  Do you have difficulties to remember peoples’ names?
2.  Você tem dificuldade para encontrar objetos de uso diário 
(chaves, óculos, relógio)?
2.  Do you have difficulties to find objects of daily use (keys, 
glasses, wristwatch)?
3.  Você tem problemas para se lembrar de acontecimentos que 
foram importantes na sua vida?
3.  Do you find it difficult to remember situations that were 
important to you?
4.  É difícil para você situar no tempo determinados 
acontecimentos?
4.  Is it hard for you to place important events in time?
5.  É difícil para você se concentrar na leitura de um livro, ou 
jornal?
5.  Do you find it hard to concentrate when reading a book or a 
newspaper? 
6.  É difícil para você se lembrar do que você leu, ou do que lhe 
disseram, recentemente?
6.  Do you have problems recalling what you have read or have 
been told recently?
7.  Você tem a sensação de que não termina o que começou? 7.  Do you have the feeling that you do not finish what you 
begin?
8.  Você tem executado de forma mais lenta as tarefas do dia-a-
dia?
8.  Does it take you longer than normal to complete your daily 
tasks?
9.  Você já se desorientou alguma vez na rua? 9.  Have you ever felt disoriented in the street?
10.  Quando alguém relembra uma conversa, ou comentário, que 
teve com você; você tem a impressão de estar ouvindo a 
informação pela primeira vez?
10.  When people remind you of a conversation or a comment you 
heard, do you get the impression that it is the first time you 
hear it?
11.  É difícil para você, em algumas ocasiões, encontrar as 
palavras certas para expressar as suas ideias?
11.  Is it sometimes difficult for you to find the words to express 
your ideas?
12.  Você se distrai com facilidade? 12.  Are you easily distracted?
13.  É complicado para você fazer cálculos simples mentalmente? 13.  Do you find it hard to do simple mental calculations?
14.  Você tem a impressão de perder o rumo da conversa? 14.  Do you get the impression that you cannot follow a 
conversation?
15.  Tem sido difícil para você aprender novas informações? 15.  Have you noticed that you find it difficult to learn new 
information?
16.  É difícil para você manter a concentração em uma tarefa 
durante muito tempo?
16.  Do you struggle to keep focused on a particular task for a long 
time?
0.  Nunca 
1.  Às vezes 
2.  Frequentemente 
3.  Sempre
0.  Never 
1.  Sometimes 
2.  Often 
3.  Always
